Three-Session Non-Surgical Periodontal Therapy Improves Biochemical and Microbiological Profiles in Patients With Severe Grade C Periodontitis
TSTG
1 other identifier
interventional
48
1 country
1
Brief Summary
This clinical study investigates two different non-surgical periodontal therapy approaches in patients with advanced periodontitis and compares them with periodontally healthy individuals. Participants with Stage III/IV Grade C periodontitis are randomly assigned to either a single-session or a three-session scaling and root planing (SRP) protocol. Clinical parameters, gingival crevicular fluid inflammatory markers, and subgingival microbial profiles are assessed at baseline and during a 6-month follow-up period. The study aims to determine whether performing non-surgical periodontal therapy in multiple sessions influences clinical, biochemical, and microbiological responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2011
CompletedFirst Submitted
Initial submission to the registry
November 13, 2025
CompletedFirst Posted
Study publicly available on registry
December 9, 2025
CompletedDecember 15, 2025
October 1, 2025
6 months
November 13, 2025
December 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Full-Mouth Mean Probing Depth (PD)
Mean change in probing depth (in millimeters) measured at six sites per tooth from baseline to 6 months.
Baseline to 6 months
Secondary Outcomes (5)
Change in Clinical Attachment Level (CAL)
Baseline, 1 month, 3 months, and 6 months after treatment
Change in Bleeding on Probing (BOP)
Baseline, 1 month, 3 months, 6 months
Change in Plaque Index (PI)
Baseline, 1 month, 3 months, 6 months
Change in Gingival Crevicular Fluid Biomarker Levels (Clusterin, Cystatin C, IL-1β, IL-6, and Osteocalcin)
Baseline, 1 month, 3 months, and 6 months after treatment
Change in Subgingival Microbiota Composition
Baseline, 1 month, 3 months, and 6 months after treatment
Study Arms (3)
Single-session non-surgical periodontal therapy
EXPERIMENTALParticipants received full-mouth scaling and root planing (SRP) completed in a single session under local anesthesia. Standard oral hygiene instructions were provided.
Three-session non-surgical periodontal therapy
EXPERIMENTALParticipants received full-mouth scaling and root planing (SRP) over three consecutive weekly sessions under local anesthesia. Standard oral hygiene instructions were provided.
Healthy control group
NO INTERVENTIONPeriodontally healthy participants without clinical attachment loss or probing depths ≥4 mm were examined and sampled but received no periodontal treatment.
Interventions
Full-mouth scaling and root planing (SRP) performed under local anesthesia, either in a single session or divided into three weekly sessions depending on the study arm. Standard oral hygiene instructions were provided to all participants.
Eligibility Criteria
You may qualify if:
- Systemically healthy, non-smoking individuals aged 18-65 years
- Diagnosis of Stage III or IV Grade C periodontitis according to the 2018 classification of periodontal diseases
- Presence of at least 20 teeth
- No periodontal treatment within the previous 6 months
- Willingness to participate and provide written informed consent
You may not qualify if:
- Presence of systemic diseases or conditions affecting the periodontium (e.g., diabetes mellitus, cardiovascular diseases, immunological disorders)
- Pregnancy or lactation
- Use of antibiotics, anti-inflammatory, or immunosuppressive drugs within the past 3 months
- History of periodontal therapy or surgery within the last 6 months
- Smoking or use of any tobacco products
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istinye University, School of Dentistry
Istanbul, Turkey, 34408, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single-blinded design: Outcome assessors were blinded to treatment allocation, while participants and care providers were aware of the assigned intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 13, 2025
First Posted
December 9, 2025
Study Start
November 21, 2010
Primary Completion
May 22, 2011
Study Completion
May 22, 2011
Last Updated
December 15, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
The individual participant data (IPD) underlying this article will not be shared because anonymized patient-level data were analyzed only in aggregate form, and no separate data repository was created for public access. Summary results are fully presented in the published article.